FDA Adverse Event Injury Summary report: N

CUP: VERSAFITCUP CC TRIO ACETABULAR SHELL 46

MDR report key: 10800548 · Received November 6, 2020

Report

Report Number
3005180920-2020-00779
Event Type
Injury
Date Received
November 6, 2020
Date of Event
October 30, 2020
Report Date
December 22, 2020
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
UDI-DI
07630030807749
PMA / PMN Number
K103352
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

VISUAL INSPECTION PERFORMED ON (B)(6) 2020. FROM THE RECEIVED PHOTOS, NO PARTICULAR OR EVIDENT SIGNS ARE PRESENT IN THE COMPONENTS, SO THERE ARE NO PARTICULAR SUSPECTS FOR A FAILURE DEVICE. ACCORDING TO WHAT STATED IN THE CLINICAL EVALUATION, A POSSIBLE CAUSE CAN BE RELATED TO THE SURGERY AND POSITIONING OF THE IMPLANT, BUT THERE IS NO CERTAINTY ON THIS.

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON (B)(6) 2020. LOT 182552: 140 ITEMS MANUFACTURED AND RELEASED ON 21-JUN-2018. EXPIRATION DATE: 2023-06-13. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 126 ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY OTHER SIMILAR REPORTED EVENT. CLINICAL EVALUATION. TWO YEARS AFTER PRIMARY CEMENTLESS THA THE CUP IS PAINFUL AND FOUND TO BE LOOSE. A CRANIAL CAVITY IS PRESENT AT THE IMPLANT-BONE INTERFACE. THE CUP WAS POSSIBLY A LITTLE TOO LATERAL, FOR UNSPECIFIED REASONS IT MAY NOT HAVE BEEN POSSIBLE TO PLACE IT AT THE BOTTOM OF THE ACETABULAR CAVITY WITH A COMPLETE REAMING OF THE SUPERIOR COLUMN. NO REASON TO THINK THAT THIS REVISION WAS CAUSED BY A DEFECTIVE IMPLANT.

Description of Event or Problem · 1

ASEPTIC CUP MOBILIZATION. THE SURGEON REVISED CUP, LINER AND HEAD 1 YEAR AND 11 MONTHS AFTER PRIMARY. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1269302 CUP: VERSAFITCUP CC TRIO ACETABULAR SHELL 46 ACETABULAR SHELL LZO MEDACTA INTERNATIONAL SA 01.26.45.0046 182552 07630030807749

Patients

Seq Age Sex Outcome Treatment
1 77 YR Required Intervention